Shockwave Reducer: Sharon’s Patient Story

Meet Sharon, a female patient from Oxfordshire, UK whose angina symptoms caused her to take lots of time off work from her job as a community care assistant. The unpredictability of her angina symptoms also impacted her social life and ability to walk any distance.

Cardiologist Dr. Jeremy Langrish (John Radcliffe Hospital, Oxford, UK) suggested the Shockwave Reducer as a treatment solution, and now, Sharon is back to work and spending time with friends and family.

Individual patient stories. Results may vary.

The physicians featured are paid consultants of Shockwave Medical. Views expressed are those of the authors and not necessarily those of Shockwave Medical.

Shockwave Reducer is commercially available in select European countries and has been implanted in over 3,500 patients. It is currently under clinical investigation in the U.S.

CAUTION: In the United States, Shockwave Reducer is an investigational device, limited by United States law to investigational use. Shockwave Reducer is subject of investigational testing and is being studied in the COSIRA-II trial in Canada. Shockwave Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability. Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events: ifu.sw-reducer.com